Initiation of pharmacological therapy in Parkinson's disease: when, why, and how-Reference-Cited by-同舟云学术

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how

Published:2020-05 Issue:5 Volume:19 Page:452-461
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

de Bie Rob M A,Clarke Carl E,Espay Alberto J,Fox Susan H,Lang Anthony E

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference91 articles.

1. Biomarker-driven phenotyping in Parkinson's disease: a translational missing link in disease-modifying clinical trials;Espay;Mov Disord,2017

2. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease;Neurology,2007

3. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease;N Engl J Med,1993

4. A 2-year, multicenter, placebo-controlled, double-blind, parallel-group study of the effect of riluzole on Parkinson's disease progression;Rascol;Mov Disord,2002

5. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease;Tetrud;Science,1989

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Body image appearance in Parkinson’s disease patients on device aided therapies;Neurological Sciences;2024-09-13

2. Automatic Transcranial Sonography-Based Classification of Parkinson’s Disease Using a Novel Dual-Channel CNXV2-DANet;Bioengineering;2024-08-31

3. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

4. Effect of Early Levodopa Treatment on Mortality in People with Parkinson's Disease;Movement Disorders Clinical Practice;2024-08-02

5. Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies;Journal of Neural Transmission;2024-07-15